Tu Nguyen, Ph.D.

Senior cell biologist - Assay Technology at Anavo Therapeutics BV

Tu Nguyen, Ph.D. has a diverse work experience spanning various roles and companies.

From October 2022, Tu has been working as a Senior Cell Biologist - Assay Technology at Anavo Therapeutics BV. Prior to this, from November 2021 to September 2022, Tu served as a Biological Scientist at Medraxa Therapeutics GmbH.

In 2021, Tu worked as a Postdoctoral Scientist at the Institute of Medical Biochemistry; Center for Molecular Biology of Inflammation.

From October 2016 to December 2020, Tu worked as a Researcher PhD Student at Westfälische Wilhelms-Universität Münster.

From November 2019 to November 2020, Tu worked as a Content Writer.

Tu's experience also includes a role as a Researcher Associate at Ajou University from 2010 to July 2016. In this role, Tu conducted experiments exploring the role and mechanism of phospholipids in brain inflammation, with a focus on Alzheimer's and Parkinson's diseases.

Tu's earlier experience includes being a Visitor Researcher at the University of Tsukuba, a Scientific Researcher at the National Key Laboratory of Plant Cell Technology, and an Assistant Sale Manager at Công Ty Hoa Kiểng Đức Uyên.

Additionally, Tu worked as a Research Assistant at Trường Đại học Nông Lâm Thành phố Hồ Chí Minh from May 2006 to October 2007.

Tu Nguyen, Ph.D. has a strong scientific background with expertise in cell biology, assay technology, and brain inflammation research.

Tu Nguyen, Ph.D. obtained a Bachelor's degree in Biotechnology In Agriculture from the Trường Đại học Nông Lâm Thành phố Hồ Chí Minh, where they studied from 2003 to 2007. Later, Tu pursued a Master's degree in Neuroscience from Ajou University, which they completed between 2010 and 2012. Recently, Tu has achieved a Ph.D. (Dr. rer.nat) in Medical Biochemistry, specializing in Lipid in Exocytosis, from the University of Münster, which they attended from 2016 to 2020.

Location

Heidelberg, Germany

Links


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Anavo Therapeutics BV

Anavo Therapeutics is the first company to systematically drug phosphatases, a rich target space previously considered undruggable for decades. We have attracted world-leading scientific expertise in phosphatase-driven disease biology and drug discovery to unlock the full potential of phosphatase-targeted allosteric modulators. In oncology, Anavois developing multiple first-in-class therapeutic programs and will build on partnerships around its platform to establish a rich pipeline across several indications


Employees

1-10

Links